Web Content Management
PRODUCTS
-
TrialKit requires minimal training for quick deployment. Its open API integrates seamlessly with databases, ideal for fast patient registry studies and high-quality data.
-
Planning to launch a patient-centric decentralized clinical trial? Give your clinical trial patients an app that makes it easy to participate—from anywhere at any time.
-
Build cell-based models of disease and accelerate therapeutic development with TARGATT™ large knock-in technology in iPSCs.
-
There are clearly defined pathways for drug approval, and choosing the right regulatory pathway for your drug development program requires a thorough understanding of sections 505(b)(1) and 505(b)(2) of the Federal Food, Drug, and Cosmetics (FD&C) Act.
-
Hospitals and other healthcare facilities depend on a variety of catheters, tubing and syringes to deliver medications and other substances to patients through vascular, enteral, respiratory, epidural and intrathecal delivery systems.
WHITE PAPERS AND CASE STUDIES
-
Building A High-Quality IND From Scratch With Strategic Gap Analysis
A biotech sponsor lacking in-house regulatory expertise engaged a partner to obtain strategic regulatory review, medical writing, project management, and electronic publishing (eCTD).
-
Newport News, VA Deploys 130,000 Mueller AMI Meters
Eight years ago, Newport News started having discussions about moving away from reading their mechanical, manually read meters every other month to go to monthly billing. Knowing they did not have adequate staffing to handle that task, the department decided to outsource its meter reading responsibilities to a third party.
-
City Of Westminster, Colorado, And The Value Of Trustworthy Data
This case study explores how the City of Westminster in Colorado has implemented a new mobile app, Trimble Unity Mobile for Cityworks, to streamline workflows and reduce manual data entry for water utility crews.
-
Accelerating The Development And Production Of High-Quality bsAbs
Bispecific antibodies (bsAbs) are revolutionizing medicine by targeting two disease mechanisms simultaneously. Learn about an innovative platform offering excellent pairing and enhanced productivity.
-
Partner Case Study: Accelerating Gene Editing Manufacturing
Beam Therapeutics partnered with ElevateBio to manufacture BEAM-101, a novel base editing therapy for sickle cell disease, advancing rapid, high-quality production towards clinical trials.
-
How Vanguard Clinical Harnesses CDMS/EDC For Faster Results
Uncover how this CRO was able to stay agile by choosing a CDMS/EDC partner that prioritized sponsor needs and streamlined operations to achieve top-tier results swiftly.
-
Re-Engineering A Complex Process For FDA Compliance
Discover the strategies that helped a company navigate a complex and shifting regulatory landscape to rapidly re-engineer a COVID-19 vaccine manufacturing process for FDA compliance.
-
Agentic AI And How It's Impacting Clinical Trial Research
Since ChatGPT’s launch in 2022, artificial intelligence has transformed industries worldwide—but the next evolution, Agentic AI, promises to be even more profound.
-
Warehouse Logistics Challenges? UWB Says, "Hold My Beer"
Struggling with outdated RFID systems, see how Budweiser Budvar Brewery turned to Ultra-Wideband (UWB) technology to tackle its complex logistics challenge.
-
Rescuing A Global Full-Service Phase III Trial For A Late-Stage Oncology Biotech
This case underscores the expertise employed in a comprehensive strategy and set of services that were used to salvage a Phase III clinical trial for ovarian cancer and ensure its timely completion.
-
eSource Purpose Is Not Just To Complete The EDC
Central eSource transforms data capture from a passive, back-end chore into an active, real-time quality and compliance engine—delivering benefits that extend beyond faster EDC feeds and reduced SDV.
-
Expanding Access To Post-Market Safety Exams For Cystic Fibrosis Medication
This study highlights the transformative impact of point-of-need care on patient access, focusing on pediatric cystic fibrosis (CF) patients requiring essential eye exams.
NEWS
-
BioLargo Invited To Showcase PFAS Treatment Technology At Industry Leading Water Conference3/10/2025
BioLargo, Inc. a company that creates and commercializes sustainable technologies to solve tough environmental and cleantech challenges, announced that it will present data demonstrating industry-leading PFAS removal and destruction from landfill leachate (the contaminant-laden water that drains from landfills) at the Air & Waste Management Association's (A&WMA) "The Science of PFAS" conference on March 12, 2025 (https://www.awma.org/pfas).
-
Microbot Medical® Announces Emory University Hospital As The First Hospital In The World To Adopt The New LIBERTY® Endovascular Robotic System11/26/2025
Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY Endovascular Robotic System, announced that Emory University Hospital, a nationally recognized academic medical center in Atlanta, has become the first hospital to adopt LIBERTY for patient care.
-
Novotech Partners With Kyungpook National University Hospital To Strengthen Clinical Trial Capabilities In South Korea3/19/2025
Novotech, a global leading full-service clinical CRO, and Acrostar, a provider of Site Management Organization (SMO) services, have entered into a strategic partnership that will support clinical trials across NHUH’s prestigious institutions including the Advanced Clinical Trials Center, the KNUH main campus, and the Chilgok KNUH in South Korea.
-
Philips Launches Next-Generation Web-Based Diagnostic Viewer For Fast, Secure Imaging Data Access Anywhere11/24/2025
Royal Philips a global leader in health technology, today announced the launch of Philips Image Management 15, the next generation of Philips Vue PACS, including a zero-footprint, web diagnostic viewer [1] that transforms how radiologists access and interpret medical images.
-
Microbes In Brooklyn Superfund Site Teach Lessons On Fighting Industrial Pollution4/15/2025
NYU Tandon-led research team discovers unprecedented genetic adaptations in Gowanus Canal organisms, revealing a potential new approach for cleaning contaminated waters and recovering valuable resources.